what to expect after first injection of semaglutide in Your Month on setpointwellness.com/wp-content/uploads/2024/10/se...
Description
GLP-1 analogs are currently being studied in clinical trials in the context of MASLD
Journal of the American Heart Association, 11(19), e025545
Intended for research purposes only
Methods Adults with T2D treated with 2 glucose-lowering agents who initiated GLP-1 RAs or basal insulin from 2010 to 2019 were propensity-score matched (1:1) and followed until October 2021 (intention-to-treat [ITT])
In a 16-week placebo-controlled study, participants using SLENDACOR alongside diet and exercise lost an average of 12 pounds and achieved results that were 6 times greater than diet and exercise alone. MyGLP-1 ProClinical delivers a comprehensive, stimulant-free approach to weight management and metabolic health
